Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NICOX-SA-25281955/news/Nicox-s-NCX-4251-Mississippi-Phase-2B-Blepharitis-Trial-Reaches-50-Enrollment-33428891/?utm_source=whatsapp&utm_medium=social&utm_campaign=share